Suppr超能文献

改善急性白血病患者静脉通路的两种方法。

Two methods for improved venous access in acute leukemia patients.

作者信息

Wade J C, Newman K A, Schimpff S C, VanEcho D A, Gelber R A, Reed W P, Wiernik P H

出版信息

JAMA. 1981 Jul 10;246(2):140-4.

PMID:7241745
Abstract

Arteriovenous fistulae and long-term indwelling right atrial (Hickman) catheters have been used as methods to improve venous access in patients with acute leukemia. The creation of 28 fistulae provided short duration of function (median, 12 days), with eight fistulae functioning less than 24 hours. Complications were negligible, and no increase in the incidence of bacteremia occurred. Fifty-one Hickman catheters have been placed, with a median placement granulocyte count of 335/microliters. The median duration of function has been 91 days or more, with 19 still functioning and 25 other catheters functioning at the time of the patient's death. Complications have been minimal, with substantial postoperative hemorrhage occurring primarily in patients with active disseminated intravascular coagulopathy at the time of catheter placement. Catheter-associated infections were uncommon. The overall incidence of bacteremia was not increased in patients with Hickman catheters, and 28 of the 30 bacteremias that occurred while catheters were in place (three catheter associated) resolved without catheter removal. The Hickman catheter is a safe, reliable device for improvement of venous access in adult patients with acute leukemia.

摘要

动静脉瘘和长期留置右心房(希克曼)导管已被用作改善急性白血病患者静脉通路的方法。28个动静脉瘘的使用功能持续时间较短(中位数为12天),其中8个动静脉瘘的功能持续时间不到24小时。并发症可忽略不计,菌血症发生率未增加。已放置51根希克曼导管,放置时粒细胞计数中位数为335/微升。功能持续时间中位数为91天或更长,19根导管仍在发挥作用,另有25根导管在患者死亡时仍在发挥作用。并发症极少,主要在置管时患有活动性弥散性血管内凝血的患者中发生大量术后出血。导管相关感染并不常见。使用希克曼导管的患者菌血症总体发生率未增加,在导管在位期间发生的30次菌血症中有28次(3次与导管相关)在不拔除导管的情况下得以缓解。希克曼导管是改善成年急性白血病患者静脉通路的一种安全、可靠的装置。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验